Pharma & Biotech Mergers & Acquisitions News
Biotechnology
Danish CNS specialist Lundbeck today revealed that it has reached to acquire Longboard Pharmaceuticals. 15 October 2024
Refine Search
Pharmaceutical
Genor Biopharma has announced plans for a significant merger with Edding Group, marking one of the first reverse takeovers involving a Hong Kong-listed biopharma company. 8 October 2024
Pharmaceutical
Pharma dealmakers appear to have largely remained on their summer holidays in a month when none of the industry's biggest players announced acquisitions. 2 October 2024
Pharmaceutical
A Feature on M&A, licensing and partnerships hotting up in inflammatory diseases as new targets present new opportunities for future growth. 30 September 2024
Pharmaceutical
Australian biotech company Telix Pharmaceuticals is to acquire USA-based RLS Radiopharmacies, expanding its manufacturing and distribution footprint in North America. 24 September 2024
Pharmaceutical
Presentations at the European Society for Medical Oncology (ESMO) Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer cachexia, a life-threatening wasting condition in cancer patients. Belgo-American drug developer iTeos Therapeutics announced mixed data at ESMO on its anti-TIGIT belrestotug, under development with UK pharma major GSK. Also of note, Germany’s BioNTech presented mid-stage at ESMO for its BNT327 in lung cancer. In other significant developments, Organon announced it is acquiring Roivant Sciences subsidiary Dermavant for up to $1.2 billion, but only $175 million upfront. Denmark’s Novo Nordisk released Phase IIa results for its recently-acquired obesity candidate monlunabant. 22 September 2024
Pharmaceutical
Women’s health specialist Organon has entered into a definitive agreement to acquire Dermavant Sciences, a Roivant company. 18 September 2024
Pharmaceutical
Bain Capital Life Sciences has announced the closing of its fourth fund, securing approximately $3 billion in total commitments. 12 September 2024
Pharmaceutical
Psyence Biomedical has announced plans to acquire Clairvoyant Therapeutics, a Canadian developer of psilocybin-based treatments. 9 September 2024
Pharmaceutical
Semnur Pharmaceuticals and Denali Capital Acquisition and special purpose acquisition company (Nasdaq: DECA, the “SPAC”), have signed an agreement and plan of merger for a proposed business combination. 4 September 2024
Pharmaceutical
Plenty of money changed hands in pharmaceutical M&A terms in August, albeit big pharma companies were largely not involved. 3 September 2024
Pharmaceutical
Last week’s research news featured a new study from Eli Lilly, showing tirzepatide – the active ingredient of its diabetes drug Mounjaro and obesity treatment Zepbound – can delay the onset of diabetes. On the financial reporting front, Denmark’s Lundbeck released strong first-half results and raised its full year guidance. A new company – Borealis Biosciences – emerged from stealth last week, with funding from Novartis and Versant Ventures. Also of note, US biotech major Regeneron had a setback, when the Food and Drug Administration (FDA) issued a complete response letter (CRL) regarding the biologics license application (BLA) for its multiple myeloma candidate linvoseltamab. 25 August 2024
Pharmaceutical
Rafael Holdings (NYSE: RFL) and Cyclo Therapeutics (Nasdaq: CYTH) have agreed to merge, with the goal of focusing on the development of Trappsol Cyclo (hydroxypropyl beta cyclodextrin). 23 August 2024
Pharmaceutical
Visiox Pharmaceuticals, a biopharma company based in Ohio, USA, has entered into a definitive merger agreement with Ocuvex Therapeutics. 20 August 2024
Pharmaceutical
Crown Laboratories, a privately held skincare company, and Nashville, USA-based Revance Therapeutics have entered into an agreement whereby the companies seek to merge the two complementary organizations. 13 August 2024
Pharmaceutical
Denmark US oncology-based Pharmacosmos today revealed it has entered a definitive agreement to acquire US cancer-focused company G1 Therapeutics. 7 August 2024
Pharmaceutical
A quiet June gave way to a busier July in pharma M&A markets. 2 August 2024
Pharmaceutical
Major pharmaceutical multinationals are looking to collaborate with Indian drug firms, leveraging their cost-efficient manufacturing capabilities, robust supply chains, and innovative research potential. 31 July 2024
Pharmaceutical
India’s Mankind Pharma has entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines (BSV) from Advent International. 26 July 2024
Pharmaceutical
US companies Palvella Therapeutics and Pieris Pharmaceuticals have agreed to merge in an all-stock transaction. 24 July 2024
Company Spotlight
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze